Deal Description

1) Innovosens is an Award winning Health tech start up based in Sweden and USA. Foundation for Innovosens was laid down based on the founders personal experience and after having lost her dad to type 2 diabetes, a disease that gave her the insight into patient needs and requirements and helped her understand the difficulties and hurdles that have to be taken when developing new connected & digital health solution for diabetic care. Innovosens has developed AI powered Glucose and Lactate metabolitetracker for Personalized health, training & wellness monitoring. SMASH (Sweat Metabolite Analysis for Sports & Health) the first non-invasive, multiparametric wearable sweat sensor for continuous monitoring of glucose and lactate and electrolyte monitoring. Through an innovative patented microfluidic system, the sensor is able to collect sweat from the skin, both the biomarkers level, and continuously replenish the reservoir with fresh sweat for updated data analyze proble Solution. By constantly monitoring the bioanalytes and making a comprehensive analysis of multiple parameters like glucose, ketone and lactate and understanding the pathophysiology of users.We want to bring the users and patients and user into sphere of disease management, early on and prevent and postpone the seviour health complications related to obesity, early and prediabetes, while also preventing the wellness and fitness groups by being lacto acidic and keto acidic.

2) Raising 1 Million USD for 15% Equity. 

3) EBITDA- 20 % in 2023, which will reach 25 % in 2024, and 50% in 2025.

Attached Files